However, the results of the coagulation assay showed some overlap between groups II and III. In addition, the immunoassay appeared to be much less laborious than the coagulation assay. Therefore, the former assay is recommended in any search for similar families.
SYNOPSIS A Dutch family (family A) with inherited antithrombin-III deficiency and an increased incidence of venous thrombosis was investigated. Antithrombin-III levels were measured by means of a coagulation assay in plasma and by single radial immunodiffusion in plasma and serum.
Three groups could be distinguished: group I comprised the relations-in-law of family A, group lI the members of family A with a plasma antithrombin-III level higher than 90 % of normal, when determined by the immunoassay, and group III the members of family A with an antithrombin-III level of less than 60 %. To group III belonged aUl eight adults with an abnormal tendency to thrombosis, and furthermore nine children, all having a parent with abnormally low antithrombin-III levels. Mean plasma and serum antithrombin-III levels were significantly decreased in group III. However, the results of the coagulation assay showed some overlap between groups II and III. In addition, the immunoassay appeared to be much less laborious than the coagulation assay. Therefore, the former assay is recommended in any search for similar families.
The results of our family investigation confirm the findings of Egeberg (1965) that inherited antithrombin-III deficiency, giving rise to plasma levels between 50 and 600% of normal, causes thrombophilia and that the pattern of inheritance is autosomal dominant.
The existence of a hypercoagulable state of circulating blood predisposing to thrombosis has been extensively investigated (for a review, see Penick, 1969) . Studies on subjects with an increased tendency to venous thrombosis have pointed to various plasma factors which might indicate or be the cause of hypercoagulability: inhibition of plasminogen activation (Nilsson, Krook, Sternby, Soderberg, and Soderstrom, 1961) , antithrombin-III deficiency (Egeberg, 1965; Von Kaulla and Von Kaulla, 1967; Penick, 1969) , elevated factor Vlevels (Gaston, 1966) , circulating antibodies against fibrinogen (Mammen, Schmidt, and Barnhart, 1967) , abnormal fibrinogen (Egeberg, 1967) , circulating fibrin monomers (Vreeken, Fedder, Van der Meer, Van Aken, Prakke, and Goote, 1972) , and deficiencyofplasminogen activator (Isacson and Nilsson, 1972 This woman became pregnant for the first time in 1967 at 32 years of age. Since the first weeks of pregnancy she had a swollen, painful leg, which was not diagnosed as thrombosis and for which no anticoagulants were given. Five days after delivery she died suddenly, probably from pulmonary embolism. In this case again, the husband (11-10) married one of his first wife's half sisters (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (Hensen and Loeliger, 1963) , were between 50 and 60 % of normal.
In October 1972 a family reunion was organized, in which all members of family A and their relationsin-law (except 111-2) participated. From all persons present (shown in fig 1) and from three members of the second generation of family B (not shown) blood was obtained. Venepuncture failed in only two babies from family A's third generation. At the time of blood sampling all members were apparently in good health. Case 11-22 was two months pregnant; she was being treated with heparin for thrombosis of a leg, which had appeared eight weeks before. In all other cases with a history of thrombosis the last episode was more than three months previously. Cases I-1 and II-26 were treated with a coumarin drug. Only two women (III-1 and III-3) used a oestrogen-containing contraceptive pill. 
Materials and Methods
Plasma was obtained from 9 ml of blood collected in 1 ml of trisodium citrate 3-8 % (w/v) by centrifuging for 10 minutes at 1200 x g. Serum was harvested after clotting of blood in glass tubes kept at 4°C for about 16 hours. All plasma and serum samples were given a randomly chosen code number. The samples were stored at -40°C. Antithrombin-III determinations were performed within three weeks after venepuncture.
ANTITHROMBIN-III ASSAYS
All antithrombin-III assays were performed in random order by one of us (Mrs E.A. S.-v.D.) without any knowledge of the clinical data.
Progressive antithrombin activity in plasma (plasma antithrombin-III coagulation) This was determined by means of a two-step coagulation assay as described by Hensen and Loeliger (1963) concluded that the pattern of inheritance of the disorder is autosomal dominant.
Discussion
The members of family A could be divided into two groups by means of the immunoassay for antithrombin-III (figs 2 and 3). The low level group (group m, table 1) comprised the eight members with a pronounced tendency to venous thrombosis. All had more or less severe signs and symptoms of venous insufficiency in the affected leg(s) at the time of investigation. Two women (11-17 and 11-22) had developed thrombosis of a leg as soon as they became pregnant, which is obviously an abnormal finding. The incidence of thrombosis during pregnancy, and especially in the puerperium, is increased, but usually this complication occurs within 14 days following delivery or during the last trimester of pregnancy (McDevitt and Smith, 1969 autosomal dominant disorder predisposing to venous thrombosis. However, the seven affected members of the Norwegian family had their first thrombotic episode at ages varying between 10 and 25, whereas in some adults of the Dutch family this happened much later or not at all. The ancestor of family A (I-1) had only one thrombotic complication during his long life. The unusual large size of family A, whose members mostly live in the same area, greatly facilitated the discovery of the disorder, which in other circumstances might have escaped attention. Conceivably, the incidence ofinherited antithrombin-III deficiency is higher than might be concluded from the scanty reports in the literature (Egeberg, 1965; Kaulla and Von Kaulla, 1967; Penick, 1969) . As oestrogen-containing contraceptives may decrease serum and plasma antithrombin-III levels (Von Kaulla and Von Kaulla, 1970; Fagerhol and Abildgaard, 1970; Gjonnaess and Fagerhol, 1971) --.
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In addition, the immunoassay is much less timeconsuming than the coagulation assay. The difference between the results of both methods could not be ascribed to a better reproducibility of the immunoassay. Antithrombin-III levels decrease with age as has been observed by Hensen and Loeliger (1963) and Egeberg (1965) 
